Neuberger Berman Group
PROF

Neuberger Berman Group’s Profound Medical PROF Stock Holding History

Neuberger Berman Group’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,300
Closed -$72.6K – 2130
2025
Q2 		$72.6K Sell
12,300
-1,250
-9% -$6.61K ﹤0.01% 1976
2025
Q1 		$78.9K Hold
13,550
– – ﹤0.01% 1894
2024
Q4 		$102K Hold
13,550
– – ﹤0.01% 1854
2024
Q3 		$108K Hold
13,550
– – ﹤0.01% 1835
2024
Q2 		$114K Buy
+13,550
New +$109K ﹤0.01% 1804

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $183M AUM 38.9% 1-Year Est. Return

Neuberger Berman Group's PROF Position: Q3 2025 in Review

Neuberger Berman Group sold out of Profound Medical (PROF) in Q3 2025, closing a stake of 12,300 shares — an estimated $72.6K sold.

Neuberger Berman Group first reported a position in PROF in Q2 2024 and held it in 5 quarters. The position peaked at $114K in Q2 2024. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2025.

  • Neuberger Berman Group reported no remaining Profound Medical position as of Q3 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 12,300 Profound Medical shares in Q3 2025, an estimated $72.6K.
  • Neuberger Berman Group first reported a position in Profound Medical in Q2 2024 and held it in 5 quarters.
  • Neuberger Berman Group's Profound Medical position peaked at $114K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2025.

Based on Neuberger Berman Group's 13F filing for Q3 2025, filed 12 Nov 2025.